Brind.

Kazia Therapeutics Limited is seeking joint bookrunning management and co-management for a proposed offering, with Leerink partners and Needham & Company involved.

Steady: 0 in the last 7 days Updated oct 15

The latest in this situation

  1. Investors participate in company financing involving Leerink partners, Needham & Company, and Ark Invest.

How it started

17 reports, 3 independent, last reported Oct 15. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Kazia Therapeutics Limited is seeking joint bookrunning management and co-management for a proposed offering, with Leerink partners and Needham & Company involved.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Investors participate in company financing involving Leerink partners, Needham & Company, and Ark Invest.1 source
  2. Kazia Therapeutics Limited announced a corporate update regarding a capital raise in Sydney.Sub-event
  3. Kazia Therapeutics seeks bookrunning management for its offering.1 source
  4. Kazia Therapeutics successfully completed a capital raise utilizing Needham & Company.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
13 more outlets ran the same wire story